Suchen Sie nach Informationen zu Lundbeck-Zentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Lundbeck

    https://www.lundbeck.com/
    Lundbeck and Otsuka announce positive results Following the positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole, Lundbeck hosted a conference call and webcast for investors and analysts on June 27 at 10:00 AM CEST to briefly discuss the topline results of the trial.

Lundbeck in the U.S.

    https://www.lundbeck.com/us/about-us/lundbeck-in-the-us
    For more than 70 years, Lundbeck has been at the forefront of brain science. We are committed to providing transformative therapies for brain diseases, and we are tirelessly dedicated to restoring brain health so every person can be their best. In the United States, our nearly 1000 employees stand shoulder-to-shoulder with patients, families ...

Products - Lundbeck

    https://www.lundbeck.com/global/brain-disorders/products
    Lundbeck has a broad range of products within brain diseases. With registered products in more than 100 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world.

Lundbeck - Wikipedia

    https://en.wikipedia.org/wiki/Lundbeck
    Lundbeck. H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's ...

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Lundbeck-Zentrale gefunden haben.